First-in-class immune-stimulating antibody conjugate BDC-4182 in Phase 1 dose escalation study, initial clinical data expected in 3Q 2026 Cash balance of $31.8 million as of December 31, 2025 ...
Vertiv Holdings Co (NYSE:VRT) has been named 2025 Company of the Year in Data Center Infrastructure for AI and HPC for its Latin American operations. The company’s LATAM division rolled out an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results